FY2022 EPS Estimates for TerrAscend Corp. (OTCMKTS:TRSSF) Raised by Analyst

TerrAscend Corp. (OTCMKTS:TRSSFGet Rating) – Investment analysts at Echelon Wealth Partners lifted their FY2022 earnings per share (EPS) estimates for shares of TerrAscend in a note issued to investors on Tuesday, November 15th. Echelon Wealth Partners analyst A. Semple now expects that the company will post earnings of ($0.18) per share for the year, up from their previous forecast of ($0.31). The consensus estimate for TerrAscend’s current full-year earnings is ($0.22) per share. Echelon Wealth Partners also issued estimates for TerrAscend’s Q4 2022 earnings at ($0.08) EPS and FY2023 earnings at ($0.24) EPS.

Several other research firms have also recently issued reports on TRSSF. Cantor Fitzgerald lowered their price objective on TerrAscend from $2.85 to $2.15 and set a “neutral” rating for the company in a research report on Friday, October 28th. Canaccord Genuity Group began coverage on TerrAscend in a research report on Monday, September 12th. They set a “buy” rating and a C$4.25 price objective for the company. Craig Hallum cut TerrAscend from a “buy” rating to a “hold” rating and lowered their price objective for the stock from $7.50 to $2.00 in a research report on Friday, August 12th. Seaport Res Ptn reaffirmed a “buy” rating on shares of TerrAscend in a research report on Friday, July 22nd. Finally, Stifel Nicolaus lowered their price objective on TerrAscend from C$6.00 to C$5.50 in a research report on Friday, August 12th. Three equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat.com, TerrAscend has an average rating of “Moderate Buy” and a consensus target price of $3.57.

TerrAscend Trading Down 4.3 %

TRSSF opened at $1.78 on Friday. TerrAscend has a 12 month low of $1.21 and a 12 month high of $6.76. The stock has a market capitalization of $448.32 million and a price-to-earnings ratio of -1.33. The company has a debt-to-equity ratio of 0.77, a current ratio of 0.66 and a quick ratio of 0.59. The business has a fifty day moving average price of $1.55 and a 200 day moving average price of $2.35.

About TerrAscend

(Get Rating)

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. It produces and distributes hemp-derived wellness products to retail locations; and manufactures cannabis infused artisan edibles. The company also operates three retail dispensaries under the Apothecarium brand name in California and Pennsylvania.

Featured Articles

Earnings History and Estimates for TerrAscend (OTCMKTS:TRSSF)

Receive News & Ratings for TerrAscend Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TerrAscend and related companies with MarketBeat.com's FREE daily email newsletter.